These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 31821004)

  • 21. An unbiased lipidomics approach identifies key lipid molecules as potential therapeutic targets of Dohongsamul-tang against non-alcoholic fatty liver diseases in a mouse model of obesity.
    Park SH; Lee JE; Lee SM; Lee J; Seo CS; Hwang GS; Jung J
    J Ethnopharmacol; 2020 Oct; 260():112999. PubMed ID: 32454173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The plasma lipidome of the Quaker parrot (Myiopsitta monachus).
    Beaufrère H; Gardhouse SM; Wood RD; Stark KD
    PLoS One; 2020; 15(12):e0240449. PubMed ID: 33259543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary metabolomics for discovering metabolic biomarkers of laryngeal cancer using UPLC-QTOF/MS.
    Chen J; Hou H; Chen H; Luo Y; Zhang L; Zhang Y; Liu H; Zhang F; Liu Y; Wang A; Hu Q
    J Pharm Biomed Anal; 2019 Apr; 167():83-89. PubMed ID: 30759408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Study of the metabolomics characteristics of patients with metabolic syndrome based on liquid chromatography quadrupole time-of-flight mass spectrometry.
    Wu N; Wang W; Yi M; Cheng S; Wang D
    Ann Endocrinol (Paris); 2018 Feb; 79(1):37-44. PubMed ID: 29246383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. UPLC-MS based plasma metabolomics and lipidomics reveal alterations associated with IgG4-related disease.
    Gong Y; Zhang P; Liu Z; Li J; Lu H; Wang Y; Qiu B; Wang M; Fei Y; Chen H; Peng L; Li J; Zhou J; Shi Q; Zhang X; Shen M; Zeng X; Zhang F; Zhang W
    Rheumatology (Oxford); 2021 Jul; 60(7):3252-3261. PubMed ID: 33341881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolomics for Age Discrimination of Ginseng Using a Multiplex Approach to HR-MAS NMR Spectroscopy, UPLC-QTOF/MS, and GC × GC-TOF/MS.
    Yoon D; Choi BR; Ma S; Lee JW; Jo IH; Lee YS; Kim GS; Kim S; Lee DY
    Molecules; 2019 Jun; 24(13):. PubMed ID: 31252608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic biomarker panels of osteoarthritis: UPLC-QToF/MS-based serum metabolic profiling.
    Lin X; He S; Wu S; Zhang T; Gong S; Minjie T; Gao Y
    PeerJ; 2023; 11():e14563. PubMed ID: 36655043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipidomic profiling of plasma samples from patients with mitochondrial disease.
    Ren C; Liu J; Zhou J; Liang H; Zhu Y; Wang Q; Leng Y; Zhang Z; Yuan Y; Wang Z; Yin Y
    Biochem Biophys Res Commun; 2018 Jun; 500(2):124-131. PubMed ID: 29627572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Study of plasma metabolic markers in unexplained recurrent spontaneous abortion based on non-target metabolomics approach].
    Liu Q; Chen LN; Li YM; Sun J; Wang YX
    Zhonghua Fu Chan Ke Za Zhi; 2024 Aug; 59(8):628-635. PubMed ID: 39187410
    [No Abstract]   [Full Text] [Related]  

  • 30. Identification of metabolic biomarkers to diagnose epithelial ovarian cancer using a UPLC/QTOF/MS platform.
    Fan L; Zhang W; Yin M; Zhang T; Wu X; Zhang H; Sun M; Li Z; Hou Y; Zhou X; Lou G; Li K
    Acta Oncol; 2012 Apr; 51(4):473-9. PubMed ID: 22283470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma metabolic profiling analysis of cyclophosphamide-induced cardiotoxicity using metabolomics coupled with UPLC/Q-TOF-MS and ROC curve.
    Yin J; Xie J; Guo X; Ju L; Li Y; Zhang Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1033-1034():428-435. PubMed ID: 27649503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic Profiling by UPLC-Orbitrap-MS/MS of Liver from C57BL/6 Mice with DSS-Induced Inflammatory Bowel Disease.
    Xin Z; Zhai Z; Long H; Zhang F; Ni X; Deng J; Yi L; Deng B
    Mediators Inflamm; 2020; 2020():6020247. PubMed ID: 33029104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipidomics biomarkers in women with polycystic ovary syndrome (PCOS) using ultra-high performance liquid chromatography-quadrupole time of flight electrospray in a positive ionization mode mass spectrometry.
    Vonica CL; Ilie IR; Socaciu C; Moraru C; Georgescu B; Farcaş A; Roman G; Mureşan AA; Georgescu CE
    Scand J Clin Lab Invest; 2019 Oct; 79(6):437-442. PubMed ID: 31462125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of potential lipid biomarkers for active pulmonary tuberculosis using ultra-high-performance liquid chromatography-tandem mass spectrometry.
    Han YS; Chen JX; Li ZB; Chen J; Yi WJ; Huang H; Wei LL; Jiang TT; Li JC
    Exp Biol Med (Maywood); 2021 Feb; 246(4):387-399. PubMed ID: 33175608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum lipidomic profiling by UHPLC-MS/MS may be able to detect early-stage endometrial cancer.
    Cheng F; Fan W; Gui L; Liu Y; Ling Y; Huang R; Wen Z; Chen Y
    Anal Bioanal Chem; 2023 Apr; 415(10):1841-1854. PubMed ID: 36799979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolomics profiling reveals altered lipid metabolism and identifies a panel of lipid metabolites as biomarkers for Parkinson's disease related anxiety disorder.
    Dong MX; Hu L; Wei YD; Chen GH
    Neurosci Lett; 2021 Feb; 745():135626. PubMed ID: 33440238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. UPLC-MS-MS-based lipidomics for the evaluation of changes in lipids during dry-cured mutton ham processing.
    Guo X; Shi D; Liu C; Huang Y; Wang Q; Wang J; Pei L; Lu S
    Food Chem; 2022 May; 377():131977. PubMed ID: 34990949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of Lipidomics for Assessing Tissue Lipid Profiles of Patients With Squamous Cell Carcinoma.
    Zeng W; Zheng W; Hu S; Zhang J; Zhang W; Xu J; Yu D; Peng J; Zhang L; Gong M; Wei Y
    Technol Cancer Res Treat; 2021; 20():15330338211049903. PubMed ID: 34761720
    [No Abstract]   [Full Text] [Related]  

  • 39. Lipidomics reveals associations between rice quality traits.
    Concepcion JCT; Calingacion M; Garson MJ; Fitzgerald MA
    Metabolomics; 2020 Apr; 16(5):54. PubMed ID: 32306193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipidomic UPLC-MS/MS Profiles of Normal-Appearing White Matter Differentiate Primary and Secondary Progressive Multiple Sclerosis.
    Pousinis P; Ramos IR; Woodroofe MN; Cole LM
    Metabolites; 2020 Sep; 10(9):. PubMed ID: 32911763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.